Risk of Stroke with Various Types of Menopausal Hormone Therapies
Stroke 48:2266-2269, Lokkegaard, E.,et al, 2017
Postmenopausal Hormone Therapy and Risk of Stroke
Stroke 47:1734-1741, Canonico, M.,et al, 2016
Transdermal and Oral Hormone Replacement Therapy and the Risk of Stroke: A Nested Case-Control Study
BMJ 340:c2519, Renoux,C., et al, 2010
Controlled Trial of High-Concentration Capsaicin Patch for Treatment of Painful HIV Neuropathy
Neurol 70:2305-2313, Simpson,D.M.,et al, 2008
Randomized, Blind, Controlled Trial of Transdermal Rotigotine in Early Parkinson Disease
Neurol 68:272-276, Watts,R.L.,et al, 2007
Advanced Parkinson Disease Treated with Rotigotine Transdermal System PREFER Study
Neurol 68:1262-1267, LeWitt,P.A.,et al, 2007
Transdermal Rotigotine: Double-Blind, Placebo-Controlled Trial in Parkinson Disease
Arch Neurol 64:676-682, Jankovic,J.,et al, 2007
A Controlled Trial of Rotigotine Monotherapy in Early Parkinson's Disease
Arch Neurol 60:1721-1728, The Parkinson Study Group, 2003
Delirium From Nicotine Withdrawal in Neuro-ICU Patients
Neurol 57:551-553, Mayer,S.A.,et al, 2001
Transderm-induced Psychosis in Parkinson's Disease
Neurol 53:433-434, Minagar,A.,et al, 1999
Syncope:Current Diagnostic Evaluation and Management
Ann Int Med 112:850-863, Manolis,A.S.,et al, 1990
Transderm Pupil & Confusion in a 10-Year-Old
Ann Neurol 13:583, Johnson,S.F.,et al, 1983
Scopalamine Psychosis Revisited
Ann Neurol 13:582, Cairncross,J.G., 1983
Cycloplegia From Transdermal Scopolamine
NEJM 306:174, Chiaramonte,J.S., 1982
Anisocoria From Scopolamine Patches
JAMA 248:353-354, McCrary,J.A.,et al, 1982